SEI Investments’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

SEI Investments’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-38,202	Closed	-$4.1M	–	2793
2023 Q1	$4.1M	Buy	38,202 +14,154	+59%	+$1.63M	0.01%	1277
2022 Q4	$2.65M	Buy	24,048 +15,392	+178%	+$998K	0.01%	1352
2022 Q3	$511K	Buy	+8,656	New	+$396K	﹤0.01%	2074
2022 Q2	–	Sell	-19,262	Closed	-$727K	–	2751
2022 Q1	$727K	Sell	19,262 -2,112	-10%	-$83.5K	﹤0.01%	1924
2021 Q4	$845K	Buy	+21,374	New	+$669K	﹤0.01%	1918

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

SEI Investments's RXDX Position: Q2 2023 in Review

SEI Investments sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 38,202 shares — an estimated $4.1M sold.

SEI Investments first reported a position in RXDX in Q4 2021 and held it in 5 quarters. The position peaked at $4.1M in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

SEI Investments reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
SEI Investments sold 38,202 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $4.1M.
SEI Investments first reported a position in Prometheus Biosciences, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
SEI Investments's Prometheus Biosciences, Inc. Common Stock position peaked at $4.1M in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on SEI Investments's 13F filing for Q2 2023, filed 11 Aug 2023.